Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as ...
Officers raided an address in the Llanrwst area following reports that prescription weight-loss drugs were being sold without ...
A notable finding is that audiences are split on whether they see more pharma ads in 2025 compared to 2024. Nearly half of ...
Novo Nordisk finds itself navigating significant operational and market headwinds. The company is intensely focused on maintaining its leadership in the obes ...
Pharmacists are urging people using weight loss injections to be alert to signs of dehydration as flu cases rise, warning ...
Amy Schumer's jaw-dropping divorce reveal has fans shook! Find out how the comedian dropped the bombshell in a way that only ...
In January, Trump RX is scheduled to launch. It will allow people to bypass insurers and other middlemen, and buy discounted drugs directly from manufacturers..
Can Novo Nordisk get its comeback going in 2026? Let's discuss two things that could materialize for the company next year ...
New research reveals that taking a GLP-1 can be equivalent to '10 years of ageing' on the body, if proper precautions aren't taken ...
Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...
The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...
Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results